Andrew David Luster

Title: The Innovations of Andrew David Luster

Introduction

Andrew David Luster is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of biomedical research, holding a total of 8 patents. His work primarily focuses on the modulation of cell movement and the development of innovative therapeutic strategies.

Latest Patents

Among his latest patents, Luster has developed multiple specificity binders of CXC chemokines. This patent provides for fusion proteins comprising multispecific variable regions that bind more than one ELR+ CXC chemokine. Another notable invention relates to the purposeful movement of human migratory cells away from an agent source. This invention includes methods and compositions for modulating the movement of eukaryotic cells with migratory capacity, particularly in treating conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject. These specific sites include areas of inflammation, tumor sites, and sites of pathogenic infection.

Career Highlights

Luster has worked with The General Hospital Corporation, where he has contributed to various research initiatives. His innovative approaches have led to advancements in understanding cell behavior and therapeutic applications.

Collaborations

Throughout his career, Luster has collaborated with notable figures in the field, including Philip Leder and Marc Elliot Rothenberg. These collaborations have further enriched his research and contributions to the scientific community.

Conclusion

Andrew David Luster's work exemplifies the intersection of innovation and biomedical research. His patents and collaborations highlight his commitment to advancing our understanding of cell movement and therapeutic strategies.